Categories: World

Finding COVID-19’s origins is a moral imperative – WHO’s Tedros

Discovering the origins of COVID-19 is a moral imperative and all hypotheses must be explored, the head of the World Health Organization said, in the clearest indication yet that the U.N. body remains committed to finding how the virus arose.

A U.S. agency was reported by the Wall Street Journal to have assessed the pandemic had likely been caused by an unintended Chinese laboratory leak, raising pressure on the WHO to come up with answers. Beijing denies the assessment which could soon become public after the U.S. House of Representatives voted this week to declassify it.

“Understanding #COVID19’s origins and exploring all hypotheses remains: a scientific imperative, to help us prevent future outbreaks (and) a moral imperative, for the sake of the millions of people who died and those who live with #LongCOVID,” Tedros Adhanom Ghebreyesus said on Twitter late on Saturday.

He was writing to mark three years since the WHO first used the word “pandemic” to describe the global outbreak of COVID-19.

Activists, politicians and academics said in an open letter this weekend that the focus of the anniversary should be on preventing a repeat of the unequal COVID-19 vaccine rollout, saying this led to at least 1.3 million preventable deaths.

In 2021, a WHO-led team spent weeks in and around Wuhan, China where the first human cases were reported and said in a joint report that the virus had probably been transmitted from bats to humans through another animal, but further research was needed. China has said no more visits are needed.

Since then, the WHO has set up a scientific advisory group on dangerous pathogens but it has not yet reached any conclusions on how the pandemic began, saying key pieces of data are missing.

Source : Reuters

GLOBAL BUSINESS AND FINANCE MAGAZINE

Recent Posts

When trade sanctions increase the target’s trade

Data show that trade sanctions reduce commerce between the countries imposing them and their targets.…

1 day ago

Competition or collusion: Entry decisions in the Swedish pharmaceutical market

Many countries have adopted different price regulations to contain pharmaceutical prices, even in markets exposed…

1 day ago

Digitalisation and credit markets: Evidence from eInvoicing

Governments around the world are increasingly mandating the digitalisation of business records, yet little is…

1 day ago

Why Europe needs Eurobonds

The 2024 reform of the EU fiscal framework makes fiscal adjustment more country-specific and less…

1 day ago

Why more information can make macroeconomic expectations less accurate: Global evidence from 47 countries

Households do not simply choose how much macroeconomic information to acquire; they choose among sources…

1 day ago

Small and stuck: Why European firms can’t scale

In 2008, the US stock market was worth $3 trillion more than the combined European…

1 day ago